PH11869A - 1-tertiary alkyl-or l-cycloakyl-3*(substituted cyclohexenyl)ureas,pharmaceutical compositions containing same and method of treatment thereof - Google Patents

1-tertiary alkyl-or l-cycloakyl-3*(substituted cyclohexenyl)ureas,pharmaceutical compositions containing same and method of treatment thereof

Info

Publication number
PH11869A
PH11869A PH17060A PH17060A PH11869A PH 11869 A PH11869 A PH 11869A PH 17060 A PH17060 A PH 17060A PH 17060 A PH17060 A PH 17060A PH 11869 A PH11869 A PH 11869A
Authority
PH
Philippines
Prior art keywords
cycloakyl
ureas
treatment
pharmaceutical compositions
compositions containing
Prior art date
Application number
PH17060A
Other languages
English (en)
Inventor
P Aldrich
B Dittmar
G Bersen
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/555,308 external-priority patent/US4002767A/en
Application filed by Du Pont filed Critical Du Pont
Publication of PH11869A publication Critical patent/PH11869A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/26—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of rings other than six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH17060A 1974-04-17 1975-04-16 1-tertiary alkyl-or l-cycloakyl-3*(substituted cyclohexenyl)ureas,pharmaceutical compositions containing same and method of treatment thereof PH11869A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46169774A 1974-04-17 1974-04-17
US52544574A 1974-11-20 1974-11-20
US05/555,308 US4002767A (en) 1974-11-20 1975-03-11 1-Tertiary-alkyl-3-(substituted cyclohexenyl)ureas as antihypertensive agents

Publications (1)

Publication Number Publication Date
PH11869A true PH11869A (en) 1978-08-04

Family

ID=27412847

Family Applications (1)

Application Number Title Priority Date Filing Date
PH17060A PH11869A (en) 1974-04-17 1975-04-16 1-tertiary alkyl-or l-cycloakyl-3*(substituted cyclohexenyl)ureas,pharmaceutical compositions containing same and method of treatment thereof

Country Status (18)

Country Link
JP (1) JPS50148337A (ja)
AR (1) AR206020A1 (ja)
CA (1) CA1051029A (ja)
CH (1) CH611273A5 (ja)
DD (1) DD119223A5 (ja)
DE (1) DE2516556A1 (ja)
DK (1) DK134318B (ja)
ES (1) ES436647A1 (ja)
FI (1) FI751127A (ja)
FR (1) FR2267766B1 (ja)
GB (1) GB1457245A (ja)
IE (1) IE40999B1 (ja)
IL (1) IL47097A (ja)
LU (1) LU72305A1 (ja)
NL (1) NL7504568A (ja)
NO (1) NO751350L (ja)
PH (1) PH11869A (ja)
SE (1) SE398116B (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0004959A1 (de) * 1978-04-24 1979-10-31 Ciba-Geigy Ag Verfahren zur Herstellung von 3-Oxo-cyclopentenylharnstoffen, die so erhaltenen Verbindungen, sie enthaltende pharmazeutische Präparate und 3-Oxo-cyclopentenylisothioharnstoffe
JPS54151218A (en) * 1978-04-24 1979-11-28 British Hovercraft Corp Ltd Split preventive device
DE3862944D1 (de) * 1987-02-09 1991-07-04 Ciba Geigy Ag Neue cyclohexandione.

Also Published As

Publication number Publication date
ES436647A1 (es) 1977-08-01
FR2267766A1 (ja) 1975-11-14
CH611273A5 (en) 1979-05-31
DE2516556A1 (de) 1975-10-30
GB1457245A (en) 1976-12-01
IE40999L (en) 1975-10-17
AU8013475A (en) 1976-10-21
DD119223A5 (ja) 1976-04-12
IL47097A (en) 1978-03-10
AR206020A1 (es) 1976-06-23
FI751127A (ja) 1975-10-18
SE398116B (sv) 1977-12-05
DK163975A (ja) 1975-10-18
DK134318B (da) 1976-10-18
NL7504568A (nl) 1975-10-21
SE7503522L (sv) 1975-10-20
FR2267766B1 (ja) 1978-10-06
IE40999B1 (en) 1979-09-26
IL47097A0 (en) 1975-06-25
CA1051029A (en) 1979-03-20
LU72305A1 (ja) 1976-03-17
JPS50148337A (ja) 1975-11-27
NO751350L (ja) 1975-10-20
DK134318C (ja) 1977-04-18

Similar Documents

Publication Publication Date Title
PH13553A (en) Pharmaceutical compositions containing 2,6 diisopropylphenol and method of use thereof
FR2329276A1 (fr) Nouvelles imidazolidines substituees, procede de preparation, application comme medicament et compositions les renfermant
CS181182B2 (en) Vehiculum of medicament and method of its produce
PH18091A (en) Novel spiro-oxazolidindiones,pharmaceutical compositions containing same and method of use thereof
PH11722A (en) 1-teritiary alkyl-3-substituted phenyl(or thietyl)ureas,pharmaceutical compositions containing same and method of treating hypertension
IL46695A (en) Substituted n-(1-benzylpyrrolidinyl-2-alkyl)-benzamides, their preparation and pharmaceutical compositions containing them
PH11250A (en) (-aryl-4)substituted piperidinoalkanol derivatives,composition and method of use thereof
IL47877A (en) Thienothiazine carboxamide derivatives,their manufacture and pharmaceutical compositions containing them
IL47413A0 (en) New 1,4-dihydropyridines,their manufacture and pharmaceutical compositions containing them
IL47735A (en) 8a-substituted-6-alkyl-ergoline i derivatives,their production and pharmaceutical compositions containing them
PH12834A (en) Pharmaceutical compositions containing 1,3-dithiol-2-ylidene derivatives and method of treatment using said composition
PH15375A (en) Sulphide compounds,pharmaceutical composition and method of use
IL50091A0 (en) New oxazolidinones,their production and pharmaceutical compositions containing them
PH12450A (en) 6-substituted 5-halogen-2,3-cresotic acid derivatives process of preparation and pharmaceutical compositions containing them
IL47015A (en) Derivatives of phenthylamino-ketones and phenthylamino-dioxolanes,their preparation and pharmaceutical compositions containing them
IL47404A0 (en) Pyrazolobenzazepines,their manufacture and pharmaceutical compositions containing them
PH13924A (en) Glavulanic acid derivatives,pharmaceutical compositions containing same and method of preparation thereof
PH14398A (en) Pharmaceutical compounds,compositions containing same and method of use
IL47590A0 (en) Vincaminic acid amides,their preparation and pharmaceutical compositions containing them
PH11869A (en) 1-tertiary alkyl-or l-cycloakyl-3*(substituted cyclohexenyl)ureas,pharmaceutical compositions containing same and method of treatment thereof
CA1032539A (en) 2-amino-6-dialkylaminodihydropyridines, their production, pharmaceutical compositions and methods of use thereof
GR61598B (en) Disubstituted phenolethers of 3-amino-2-hydroxypropan,preparation process thereof and use thereof as medicines
IL46823A0 (en) New dibenzazepine derivatives,their manufacture and pharmaceutical compositions containing them
IL47969A (en) N-acyl orgoteins, their production and pharmaceutical compositions containing them
IL46448A0 (en) New thioamides,their manufacture and pharmaceutical compositions containing them